Accelerate Diagnostics major shareholder Purchases $213,459 in Stock (AXDX)
Accelerate Diagnostics (NASDAQ:AXDX) major shareholder Larry N. Feinberg bought 16,307 shares of the stock on the open market in a transaction dated Monday, January 27th. The shares were purchased at an average cost of $13.09 per share, with a total value of $213,458.63. Following the completion of the acquisition, the insider now directly owns 20,000 shares of the company’s stock, valued at approximately $261,800. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.
Accelerate Diagnostics (NASDAQ:AXDX) traded up 2.14% on Tuesday, hitting $13.35. 34,996 shares of the company’s stock traded hands. Accelerate Diagnostics has a 52 week low of $4.20 and a 52 week high of $16.45. The stock’s 50-day moving average is $13.35 and its 200-day moving average is $11.58. The company’s market cap is $553.6 million.
Accelerate Diagnostics, Inc, formerly Accelr8 Technology Corporation, is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.